Boryung Pregabalin Capsule 300 mg

Adult dose

This drug is administered orally in divided doses of the total daily dose twice a day without regard to meals. 1. Neuropathic Pain - Peripheral neuropathic pain: Starting dose is 150 mg per day; it can be increased to 300 mg per day after 3 to 7 days, and if necessary, it may be further increased to a maximum of 600 mg in 7-day intervals. - Central neuropathic pain: Starting dose is 150 mg per day, increased to 300 mg after one week.

This drug affects the central nervous system, and there is a risk of suicidal thoughts, suicidal behavior, or depression symptoms during treatment; therefore, patients and caregivers should closely monitor for such changes. This drug should not be taken by patients with certain genetic disorders, especially those with lactose intolerance. Diabetic patients may need to adjust their blood sugar control medications due to weight gain after taking this drug; caution is advised. An allergic reaction such as angioedema may occur; if symptoms such as swelling of the face or around the mouth appear, treatment should be discontinued immediately. Elderly patients should exercise caution as the use of this drug may increase dizziness or drowsiness, raising the risk of falls or injuries. Some patients may experience blurred vision or changes in eyesight after taking this drug, and these symptoms may improve upon discontinuation of the medication. Discontinuation of this medication may cause withdrawal symptoms such as insomnia, headache, and anxiety; therefore, it should not be abruptly stopped and should follow a doctor's advice. There is a potential for drug abuse or dependence, so patients with a history of drug abuse should be closely monitored. Patients with impaired kidney function should have their dosage adjusted, and those with heart disease should also use caution. Caution is needed when taking this drug with opioid analgesics, as it can increase central nervous system depression, which risks respiratory depression. In early pregnancy, taking this drug may impact the fetus; therefore, pregnant women or those planning to become pregnant should consult their physician and use effective contraception. Women who are breastfeeding should consult their physician as this drug may be passed into breast milk and affect the infant. They may need to stop breastfeeding or discontinue the drug. Caution is advised when engaging in hazardous activities such as driving or operating machinery, as dizziness or drowsiness may occur after taking this drug. This drug should be kept out of reach of children, and transferring it to another container may pose risks of accidents and degradation of quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory difficulties accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and very severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urinary disturbances.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This drug may be sensitive to air or moisture; it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with a brown upper part and white lower part containing a white or light yellow powder.

Package unit

30 capsules per bottle, 100 capsules per bottle